Glucosamine may retard atherogenesis by promoting endothelial production of heparan sulfate proteoglycans
- 31 March 1997
- journal article
- Published by Elsevier BV in Medical Hypotheses
- Vol. 48 (3), 245-251
- https://doi.org/10.1016/s0306-9877(97)90328-5
Abstract
Heparan sulfate proteoglycans produced by vascular endothelium may function physiologically to restrain the migration, multiplication, and phenotypic transition of vascular smooth-muscle cells, and to maintain an anticoagulant luminal surface by bonding and activating antithrombin III. Thus, ample production of heparan sulfate proteoglycans may act to prevent atherosclerosis and its thrombotic complications. The ability of exogenous heparin to stimulate synthesis of heparan sulfate proteoglycans by vascular endothelium may be largely responsible for the positive outcomes of most controlled evaluations of low-dose heparin as a long-term therapy for coronary disease. Glucosamine, a biosynthetic precursor of mucopolysaccharides, can substantially enhance mucopolysaccharide production when added to cultured fibroblasts or chondrocytes; the clinical utility of oral glucosamine in osteoarthritis may reflect increased synthesis of cartilage proteoglycans. It is reasonable to speculate that exogenous glucosamine will likewise enhance heparan sulfate proteoglycans production by vascular endothelial cells, and, when administered orally in regimens comparable to those effective in osteoarthritis, will thereby act to retard atherogenesis.Keywords
This publication has 65 references indexed in Scilit:
- Contribution of endogenous generation of endothelin-1 to basal vascular toneThe Lancet, 1994
- Regulatory Functions of the Vascular EndotheliumNew England Journal of Medicine, 1990
- Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell culturesBiochemistry, 1988
- An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells.The Journal of cell biology, 1985
- Anticoagulantly active heparin-like molecules from vascular tissueBiochemistry, 1984
- Anti-clotting activity of endothelial cell cultures and heparan sulfate proteoglycansBiochemical and Biophysical Research Communications, 1982
- Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growthThe Journal of cell biology, 1981
- Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin.Circulation Research, 1980
- Suppression by heparin of smooth muscle cell proliferation in injured arteriesNature, 1977
- Atherosclerosis and the Arterial Smooth Muscle CellScience, 1973